. 2022 Mar 9;2022:1966798. doi: 10.1155/2022/1966798

Table 2.

A comparative study on the related parameters among different age groups of women in Qingdao, China ( $\bar{x}$ ± s).

Groups	18–24 (n = 120)	25–39 (n = 120)	40–49 (n = 120)	50–64 (n = 120)	>65 (n = 60)	F	P
FBG (mmol/L)	4.66 ± 0.34	4.55 ± 0.38^a	4.82 ± 0.41^ab	5.05 ± 0.49^abc	5.21 ± 0.44^abcd	46.789	<0.001
ALT (IU/L)	12.01 ± 5.78	12.43 ± 5.84	16.63 ± 9.86^ab	17.55 ± 7.56^ab	16.65 ± 6.21^ab	19.606	<0.001
AST (IU/L)	15.37 ± 3.67	14.66 ± 3.27	16.92 ± 5.13^ab	18.64 ± 4.11^abc	19.24 ± 4.34^abc	28.114	<0.001
BUN (mmol/L)	4.27 ± 0.91	4.24 ± 1.01	4.83 ± 1.13^ab	5.21 ± 1.17^abc	5.64 ± 1.33^abcd	31.985	<0.001
Cr (Umol/L)	83.46 ± 7.05	79.67 ± 8.50^a	83.09 ± 8.10^b	82.51 ± 7.19^b	86.22 ± 7.93^bcd	8.782	<0.001
Hb (g/L)	134.52 ± 8.54	132.621 ± 8.09	134.07 ± 9.84	137.32 ± 9.10^abc	133.65 ± 8.27^d	6.609	<0.001
TSH (uIU/mL)	2.04 ± 0.80	2.31 ± 1.09^a	1.83 ± 0.85^ab	2.04 ± 1.09^bc	2.36 ± 1.37^c	6.324	<0.001
FT3 (pmol/L)	4.45 ± 0.44	4.12 ± 0.51^a	4.10 ± 0.63^a	4.46 ± 0.39^bc	4.35 ± 0.36^bc	21.227	<0.001
TT3 (ng/mL)	1.09 ± 0.14	1.01 ± 0.17^a	1.00 ± 0.17^a	1.09 ± 0.12^bc	1.09 ± 0.12^bc	14.559	<0.001
FT4 (pmol/L)	13.82 ± 1.17	12.88 ± 1.36^a	12.87 ± 1.49^a	13.31 ± 1.08^abc	13.22 ± 1.05^a	15.963	<0.001
TT4 (μg/dL)	8.22 ± 1.30	7.59 ± 1.16^a	7.67 ± 1.21^a	8.02 ± 1.06^bc	7.87 ± 1.27	7.955	<0.001
VB12 (pmol/L)	412.56 ± 183.66	438.51 ± 178.20	507.16 ± 236.94^ab	556.59 ± 245.61^abc	480.22 ± 202.74^d	11.874	<0.001
CYFRA 21-1 (ng/mL)	1.21 ± 0.63	1.36 ± 0.75	1.05 ± 0.56^b	1.52 ± 1.86^ac	1.55 ± 0.90^c	4.509	0.001
SCC (ng/mL)	0.92 ± 0.34	0.95 ± 0.38	0.74 ± 0.28	1.00 ± 0.36	0.70 ± 0.30	0.563	0.690
Anti-TG (IU/mL)	12.05 ± 65.33	17.51 ± 67.93	19.04 ± 87.20	16.63 ± 73.09	2.16 ± 2.91	0.561	0.691
Anti-TPO (IU/mL)	5.97 ± 41.55	15.38 ± 80.93	30.20 ± 120.93^a	10.06 ± 46.23^c	0.35 ± 0.32^c	2.796	0.025
Ferritin (ng/mL)	40.21 ± 33.81	46.82 ± 37.27	38.59 ± 30.89	77.62 ± 46.71^abc	89.91 ± 60.37^abc	37.155	<0.001

Note: AP < 0.05 compared with the 18–24-year-old group; BP < 0.05 compared with the 25–39-year-old group; CP < 0.05 compared with the 40–49-year-old group; DP < 0.05 compared with the 50–64-year-old group.